Home > A. Molecular pathology > ADAR2
ADAR2
Sunday 20 August 2017
Pathology
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
- ADAR2 is overexpressed in EC and that the increase in expression positively correlates with the aggressiveness of the tumor.
- Furthermore, silencing of ADAR2 in three EC cell lines resulted in a decreased proliferation rate, increased apoptosis, and reduced migration capabilities in vitro.
- ADAR2 functions as an oncogene in endometrial carcinogenesis and could be a potential target for improving EC treatment strategies.
- doi : 10.1038/s41598-017-09169-2
See also